Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of MYC Oncoprotein Expression on Survival Outcome in Secondary AML Patients

Seongseok Yun, MD PhD, Rohit Sharma, MD, David A Sallman, MD, Nicole D. Vincelette, PhD, Kendra L. Sweet, MD, Eric Padron, MD, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Lynn C. Moscinski, MD, John Cleveland, PhD, Alan F. List, MD, Ling Zhang, MD

Blood (2018) 132 (Supplement 1): 2756.

https://doi.org/10.1182/blood-2018-99-120048

Published: 2018

Journal Articles

Incidence, Risk, and Markers of Thrombosis in AML Patients - Single Institution Experience

Blood (2018) 132 (Supplement 1): 5880.

https://doi.org/10.1182/blood-2018-99-120332

Published: 2018

Journal Articles

Validation of the Khorana Score in Acute Myeloid Leukemia Patients: A Single Institution Experience

Sayeef Mirza, MD MPH, Seongseok Yun, MD PhD, Najla Al Ali, M.Sc, Maher Elharake, MD, Nathan Visweshwar, MD, Daniel Schwartz, Katherine Robinson, MD, Ethan Nowell, BS, Grace Engle, Ibraahim Badat, Thomas Brimer, MD, Amra Kuc, Ashton Sequeira, MD, Sabbir Mirza, Dhiraj Sikaria, Jesus Diaz Vera, Noah Hackney, Rami S. Komrokji, MD, Michael Jaglal, MD

Blood (2018) 132 (Supplement 1): 2278.

https://doi.org/10.1182/blood-2018-99-117545

Published: 2018

Journal Articles

Clonal Suppression of TP53 Mutant MDS and Oligoblastic AML with Hypomethylating Agent Therapy Improves Overall Survival

David A Sallman, MD, Najla Al Ali, M.Sc, Seongseok Yun, MD PhD, Eric Padron, MD, Jinming Song, MD PhD, Mohammad Omar Hussaini, MD, Chetasi Talati, MD, Kendra L. Sweet, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Rami S. Komrokji, MD

Blood (2018) 132 (Supplement 1): 1817.

https://doi.org/10.1182/blood-2018-99-117297

Published: 2018

Journal Articles

Prognostic Impact of Concurrent BCR/ABL1 Gene Rearrangement on Survival Outcome in Ph-like B-ALL Patients

Seongseok Yun, MD PhD, Nicole D. Vincelette, PhD, Jeffrey E. Lancet, MD, Julio C. Chavez, MD, Bijal D. Shah, MD, Ling Zhang, MD

Blood (2017) 130 (Supplement 1): 5114.

https://doi.org/10.1182/blood.V130.Suppl_1.5114.5114

Published: 2017

Journal Articles

Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review

Pavan Tenneti, MD, Umar Zahid, MD, Ahmad Iftikhar, MD, Seongseok Yun, MD PhD, Vikas Kapoor, MD, Azka Latif, MD, Adeela Mushtaq, MD, Raahem Nayab Zafar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 2014.

https://doi.org/10.1182/blood.V130.Suppl_1.2014.2014

Published: 2017

Journal Articles

Economic Evaluation for the US of Venetoclax Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion

Nimer Alsaid, Ali McBride, PharmD,MS, Mok Oh, Daniel Persky, MD, Faiz Anwer, MD, Leslie Andritsos, MD, Abhijeet Kumar, Seongseok Yun, MD PhD, Ivo Abraham, PhD RN

Blood (2017) 130 (Supplement 1): 4678.

https://doi.org/10.1182/blood.V130.Suppl_1.4678.4678

Published: 2017

Journal Articles

Economic Evaluation for the US of Ibrutinib Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion

Nimer Alsaid, Ali McBride, PharmD,MS, HyunJung Kim, Mok Oh, Leslie Andritsos, MD, Faiz Anwer, MD, Daniel Persky, MD, Abhijeet Kumar, Seongseok Yun, MD PhD, Ivo Abraham, PhD RN

Blood (2017) 130 (Supplement 1): 4679.

https://doi.org/10.1182/blood.V130.Suppl_1.4679.4679

Published: 2017

Journal Articles

Prognostic Impact of TP53 Mutation in Combination with Chromosome 17p Deletion in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Seongseok Yun, MD PhD, Jose Sandoval-Sus, MD, Todd C Knepper, PharmD, Jamie Teer, PhD, Julio C. Chavez, MD, Javier Pinilla-Ibarz, MD PhD

Blood (2017) 130 (Supplement 1): 5320.

https://doi.org/10.1182/blood.V130.Suppl_1.5320.5320

Published: 2017

Journal Articles

Adherence to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia: Meta-Analyses of Prevalence Rates By Measurement Method

Ziyad Alrabiah, PharmD, BCPS, Abdulaziz Alhossan, PharmD, BCPS, Seongseok Yun, MD PhD, Karen MacDonald, PhD, Ivo Abraham, PhD

Blood (2016) 128 (22): 3610.

https://doi.org/10.1182/blood.V128.22.3610.3610

Published: 2016

Journal Articles

Risk of Atrial Fibrillation and Bleeding Diathesis Associated with Ibrutinib Treatment: A Pooled-Analysis of Four Randomized Trials

Seongseok Yun, MD PhD, Nicole D. Vincelette, PhD, Utkarsh Acharya, DO, Ivo Abraham, PhD

Blood (2016) 128 (22): 5584.

https://doi.org/10.1182/blood.V128.22.5584.5584

Published: 2016

Journal Articles

Cost-Effectiveness Evaluation for the US of Fondaparinux Compared to Argatroban in the Management of Suspected HIT

Ahmed Aljabri, Pharm.D., Mahdi Gharaibeh, MSc., Yvonne Huckleberry, Pharm.D., Hussam Kutbi, Pharm.D., Yuval Raz, MD, Seongseok Yun, MD PhD, Ivo Abraham, PhD, Brian Erstad, Pharm.D.

Blood (2015) 126 (23): 4727.

https://doi.org/10.1182/blood.V126.23.4727.4727

Published: 2015

Journal Articles

mTOR Dual Inhibitor Induced Cytotoxicity Depends on 4EBP1/c-Myc/Puma and NFkB/Egr-1/Bim Pathways in Human Lymphoid Malignancies

Seongseok Yun, MD PhD, Nicole D. Vincelette, Katherine L. B. Knorr, PhD, Luciana L. Almada, PhD, Paula A. Schneider, Kevin L. Peterson, PhD, Karen S. Flatten, Allan D. Hess, PhD, B. Douglas Smith, MD, Judith E. Karp, MD, Martin E. Fernandez-Zapico, MD, Scott H. Kaufmann, MD PhD

Blood (2015) 126 (23): 3705.

https://doi.org/10.1182/blood.V126.23.3705.3705

Published: 2015

Journal Articles

Assessing the Mechanism of Cytarabine-Induced Killing in Acute Leukemia

Nicole Dionne Vincelette, Seongseok Yun, MD, PhD

Blood (2014) 124 (21): 5210.

https://doi.org/10.1182/blood.V124.21.5210.5210

Published: 2014

NARROW

Prognostic Impact of MYC Oncoprotein Expression on Survival Outcome in Secondary AML Patients

Incidence, Risk, and Markers of Thrombosis in AML Patients - Single Institution Experience

Validation of the Khorana Score in Acute Myeloid Leukemia Patients: A Single Institution Experience

Clonal Suppression of TP53 Mutant MDS and Oligoblastic AML with Hypomethylating Agent Therapy Improves Overall Survival

Prognostic Impact of Concurrent BCR/ABL1 Gene Rearrangement on Survival Outcome in Ph-like B-ALL Patients

Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review

Economic Evaluation for the US of Venetoclax Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion

Economic Evaluation for the US of Ibrutinib Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion

Prognostic Impact of TP53 Mutation in Combination with Chromosome 17p Deletion in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Adherence to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia: Meta-Analyses of Prevalence Rates By Measurement Method

Risk of Atrial Fibrillation and Bleeding Diathesis Associated with Ibrutinib Treatment: A Pooled-Analysis of Four Randomized Trials

Cost-Effectiveness Evaluation for the US of Fondaparinux Compared to Argatroban in the Management of Suspected HIT

mTOR Dual Inhibitor Induced Cytotoxicity Depends on 4EBP1/c-Myc/Puma and NFkB/Egr-1/Bim Pathways in Human Lymphoid Malignancies

Assessing the Mechanism of Cytarabine-Induced Killing in Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only